Brainsway (BRSYF) Curent Deferred Tax Liability (2019 - 2026)
Brainsway's (BRSYF) quarterly Curent Deferred Tax Liability came in at $9.8 million in Q2 2026, up 38.32% on a YoY basis from $7.1 million in Q2 2025, and up 25.32% quarter-over-quarter from $7.8 million in Q1 2026.
Analysis
Brainsway (BRSYF) Curent Deferred Tax Liability (2019 - 2026) Analysis & Trends
Brainsway (BRSYF) has reported Curent Deferred Tax Liability for 8 consecutive years, with $9.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Curent Deferred Tax Liability rose 38.32% year-over-year to $9.8 million; the trailing twelve-month figure through Jun 2026 stood at $9.8 million (up 38.32% YoY), and the FY2025 full-year result was $6.8 million, up 86.54% from the prior year.
- Curent Deferred Tax Liability grew to $9.8 million in Q2 2026 per BRSYF's latest filing, from $7.8 million in the prior quarter.
- Across five years, Curent Deferred Tax Liability topped out at $9.8 million in Q2 2026 and bottomed at $273000.0 in Q1 2022.
- Historically, Curent Deferred Tax Liability has averaged $4.5 million across 5 years, with a median of $5.3 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Curent Deferred Tax Liability plunged 61.26% in 2022, then soared 572.66% in 2023.
- Over 5 years, Curent Deferred Tax Liability stood at $790000.0 in 2022, then jumped by 572.66% to $5.3 million in 2023, then slumped by 31.78% to $3.6 million in 2024, then soared by 86.54% to $6.8 million in 2025, then jumped by 45.31% to $9.8 million in 2026.
- According to Business Quant data, Curent Deferred Tax Liability over the past three periods registered $9.8 million, $7.8 million, and $6.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax Liability (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.63 Bn | 175.03 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.57 Bn | 122.36 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.86 Bn | 108.04 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.03 Bn | 100.55 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.67 Bn | 63.14 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.75 Bn | 45.50 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 20.70 Bn | 20.22 Bn | 684.20 Mn | - |
| 10 | Brainsway | 592.58 Mn | 529.41 Mn | 12.77 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.83 Mn |
| Mar 31, 2026 | 7.84 Mn |
| Dec 31, 2025 | 6.76 Mn |
| Sep 30, 2025 | 6.47 Mn |
| Jun 30, 2025 | 7.10 Mn |
| Mar 31, 2025 | 7.35 Mn |
| Dec 31, 2024 | 3.63 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Dec 31, 2023 | 5.31 Mn |
| Mar 31, 2023 | 700,000.00 |
| Dec 31, 2022 | 790,000.00 |
| Sep 30, 2022 | 1.10 Mn |
| Mar 31, 2022 | 273,000.00 |
| Dec 31, 2021 | 2.04 Mn |
| Sep 30, 2021 | 439,000.00 |
| Jun 30, 2021 | 212,000.00 |
| Mar 31, 2021 | 162,000.00 |
| Dec 31, 2020 | 320,000.00 |
| Jun 30, 2020 | 52,000.00 |
| Dec 31, 2019 | 555,000.00 |